Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04088708 · ClinicalTrials.gov registry record · NA
Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors
A NA study of Breast Cancer and Fatigue, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT04088708: Active NA study of Breast Cancer and Fatigue, sponsored by University of Alabama at Birmingham.
NCT04088708 is a NA study of Breast Cancer and Fatigue that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 126 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04088708, a NA study of Breast Cancer and Fatigue, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this project is to determine the effects of exercise on the gut microbiome in breast cancer survivors and determine how these changes may relate to psychosocial symptoms such as fatigue.
Primary Outcome
Using standard diversity and taxa comparison metrics
Conditions Studied
Interventions
- OTHER Attention Control
- OTHER Aerobic Exercise Training
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2020-01-17 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT04088708 still lists
NCT04088708 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT04088708 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04088708 about?
NCT04088708 is a clinical study titled "Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors". The primary goal of this project is to determine the effects of exercise on the gut microbiome in breast cancer survivors and determine how these changes may relate to psychosocial symptoms such as fatigue.
What is the current status of trial NCT04088708?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2020-01-17. Estimated completion is 2026-08-31.
What conditions does trial NCT04088708 study?
This clinical trial studies the following conditions: Breast Cancer, Fatigue, Exercise, Gut Microbiome.
What interventions are being tested in trial NCT04088708?
The interventions under investigation include: Attention Control (OTHER), Aerobic Exercise Training (OTHER).
Who is sponsoring clinical trial NCT04088708?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04088708 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04088708's enrollment target sits among peer trials
126 497th of 1224 higher than 727 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI